semaglutide las vegas med spa Take Control of Your Weight

Data indicates cardiovascular protective benefits from taking the obesity drug Wegovy

Learn about FDA warnings, potential mechanisms linking tirzepatide to mood changes, and when to contact your healthcare provider about emotional side effects during weight loss treatment.

Current annual therapy cost: ~1.51.7 lakh per patient At 5060% lower pricing: ~70,00085,000 per year Savings of nearly 80,0001,00,000 per patient annually Now consider scale: 100,000 patients 75,000 750 crore annual market 500,000 patients (just ~0.5% of high-risk obese population) 3,750 crore opportunity And thats only drug revenue

2.2% (5.1 lbs) with placebo

Schedule a consultation today to learn more.

Not approved for human or veterinary use.